Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

167.66
-0.0900-0.05%
Pre-market: 167.53-0.1300-0.08%04:01 EDT
Volume:7.43M
Turnover:1.24B
Market Cap:43.54B
PE:-11.79
High:168.20
Open:167.79
Low:166.18
Close:167.75
52wk High:176.60
52wk Low:133.73
Shares:259.67M
Float Shares:259.67M
Volume Ratio:0.86
T/O Rate:2.86%
Dividend:2.53
Dividend Rate:1.51%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.27
PE(LYR):-11.79

Loading ...

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
15 hours ago

U.S. Stocks on the MOVE-Forgent Power, Vera Bradley, Wells Fargo

Reuters
·
16 hours ago

Health Care Roundup: Market Talk

Dow Jones
·
16 hours ago

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Yesterday

As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards

Reuters
·
Yesterday

JLL Income Property Trust Expands Healthcare Real Estate Portfolio

TIPRANKS
·
Yesterday

Kantone Warns of Profit Drop on Weaker U.K. Healthcare System Sales

TIPRANKS
·
Yesterday

Healthcare Realty Trust Price Target Cut to $20.00/Share from $21.00 by Jefferies

Dow Jones
·
Yesterday

LIVE Markets-Autumn in New York: Factory Expansion Slows, Input Prices at Multi-Year Highs - Empire State

Reuters
·
Yesterday

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Yesterday

LIVE Markets-US Stock Indexes Swing Lower as Oil, Yields Jump

Reuters
·
Yesterday

Alignment Healthcare says not changing guidance

TIPRANKS
·
Yesterday

Abbvie Exec Says Will Present Late-Stage Data for Blood Cancer Drug Etentamig at International Myeloma Society Meeting Later in September - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Existing Portfolio Provides 'Clear Line of Sight' to Very Strong Growth Well into Next Decade - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Apogee Fits 'Very Nicely' with Its Business Development Approach - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Plans to Start Enrolling Apogee's Zumilokibart This Year, Targets Launch in Early 2030 - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Tavapadon U.S. Launch Expected to Have 'Slower Burn' Due to Timing of Medicare Reimbursement - Conf Call

THOMSON REUTERS
·
Yesterday

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Dow Jones
·
Yesterday

Alignment Healthcare not commenting on CMS Plan Preview 2

TIPRANKS
·
Yesterday

Alignment Healthcare shares drop 12.7% after speaking at Baird conference

TIPRANKS
·
Yesterday